Dr. Kathleen Uhl
Regulatory news now as the US Food and Drug Administration (FDA) has announced Dr. Kathleen Uhl will serve as acting director of the Office of Generic Drugs (OGD).
Dr. Uhl has worked at the FDA for 15 years and has been credited with forging new relationships with other federal agencies and the scientific community.
And Dr. Uhl may well become one of the figures behind such guidance as the recent ‘tablet scoring’ guidelines which you can read about right here.